Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anaplastic Cancer
Studies from Hallym University have provided new information about anaplastic cancer
May 18th, 2008
"Anaplastic thyroid carcinoma is rare but is one of the most aggressive malignancies. Therefore, accurate diagnosis is important in order to provide appropriate therapy," scientists in Seoul, South Korea report. "To establish useful computed tomographic (CT) criteria for differentiating anaplastic carcinoma from other thyroid masses. The CT scans of nine patients with anaplastic carcinomas were retrospectively reviewed and compared with those of 32 patients with papillary carcinomas (n=12) or benign lesions (n=20) exceeding a maximum diameter of 2.0 cm. Image analysis was performed according to the following CT parameters: size, margin (well defined or ill defined),...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-18)
|
